MAPK and angiotensin II receptor in kidney of newborn rats from losartan-treated dams

Pediatric Nephrology

Volumn 23, Issue 9, 2008, Pages 1433-1444

  Balbi, Ana Paula Coelho ^a   Marin, Evelyn Cristina Santana ^a   Francescato, Heloisa Della Coletta ^a   Costa, Roberto Silva ^a   Coimbra, Terezila Machado ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Angiotensin II; Angiotensin II receptor; Lactation; Losartan; MAPK; Renal development

Indexed keywords

ALBUMIN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; LOSARTAN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; STRESS ACTIVATED PROTEIN KINASE; SUCROSE;

ALBUMINURIA; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; GLOMERULUS FILTRATION RATE; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; KIDNEY CORTEX; KIDNEY DEVELOPMENT; KIDNEY FUNCTION; KIDNEY STRUCTURE; LACTATION; NEPHROTOXICITY; NEWBORN; NONHUMAN; POSTNATAL CARE; PRIORITY JOURNAL; PROGENY; PROTEIN EXPRESSION; RAT; WESTERN BLOTTING;

ACTINS; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; ANIMALS, NEWBORN; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; JNK MITOGEN-ACTIVATED PROTEIN KINASES; KIDNEY; LOSARTAN; MAP KINASE SIGNALING SYSTEM; RATS; RATS, WISTAR; RECEPTORS, ANGIOTENSIN;

EID: 47849131956     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-008-0830-1     Document Type: Article

References (45)

1. Nigam SK, Aperia AC, Brenner BM (1996) Development and maturation of the kidney. In: Brenner BM, Rector FC Peds) The kidney: physiology and pathology, 5th edn. WB Saunders, Philadelphia pp 72-98
2. Reeves W, Caulfield JP, Farquhar MG (1978) Differentiation of epithelial foot processes and filtration slits: Sequential appearance of occluding junctions, epithelial polyanion and slit membranes in developing glomeruli. Lab Invest 39:90-100
3. Roberts AB, McCune BK, Sporn MB (1992) TGF-b: Regulation of extracellular matrix. Kidney Int 41:557-559
4. Thiery JP, Duband JL, Dufour S, Savagner P, Imhof BA (1989) Role of fibronectins in embryogenesis. In: Mosher DF (ed) Biology of extracellular matrix: Fibronectin. Academic Press, Inc, San Diego, pp 181-212
5. Kagami S, Border WA, Miller DE, Noble NA (1994) Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-b expression in rat glomerular mesangial cells. J Clin Invest 93:2431-2437
6. Bagby SP, Holden W (1988) Angiotensin II stimulates proliferation of aortic endothelial cells. Clin Res 36:259A
7. Woolf AS, Winyard PJ (1998) Advances in the cell biology and genetics of human kidney malformations. J Am Soc Nephrol 9:1114-1125
8. Gomez RA, Lynch KR, Sturgill BC, Elwood JP, Chevalier RL, Carey RM, Peach MJ (1989) Distribution of renin mRNA and its protein in the developing kidney. Am J Physiol 257:F850-F858
9. Gomez RA, Tufro-McReddie A, Everett AD, Pentz ES (1993) Ontogeny of renin and AT1 receptor in the rat. Pediatr Nephrol 7:635-638
10. Millan MA, Carvallo P, Izumi S, Zemel S, Catt KJ, Aguilera G (1989) Novel sites of expression of functional angiotensin II receptors in the late gestation fetus. Science 244:1340-1342
11. Tufro-McReddie A, Harrison JK, Everett AD, Gomez RA (1993) Ontogeny of angiotensin II type 1 receptor gene expression in the rat. J Clin Invest 91:530-537
12. Grady EF, Sechi LA, Griffin CA, Schambelan M, Kalinyak JE (1991) Expression of AT2 receptors in the development rat fetus. J Clin Invest 88:921-933
13. Yosypiv IV, Schroeder M, El-Dahr SS (2006) Angiotensin II type 1 receptor-EGF receptor cross-talk regulates ureteric bud branching morphogenesis. J Am Soc Nephrol 17:1005-1014
14. Bokemeyer D, Sorokin A, Dunn MJ (1996) Multiple intracellular MAP kinase signaling cascades. Kidney Int 49:1187-1198
15. Xia Z, Dickens M, Raingeaud J, Davis RJ, Greenberg ME (1995) Opposing effects of ERK and JNK- p38 MAP kinases on apoptosis. Science 270:1326-1331
16. Omori S, Hida M, Ishikura K, Kuramochi S, Awazu M (2000) Expression of mitogen-activated protein kinase family in rat renal development. Kidney Int 58:27-37
17. Kubo T, Ibusuki T, Chiba S, Kambe T, Fukumori R (2001) Mitogen activated protein kinase activity regulation role of angiotensin and endothelin systems in vascular smooth muscle cells. Eur J Pharmacol 411:27-34
18. Kumar D, Menon V, Ford WR, Clanachan AS, Jugdutt BI (2004) Effect of angiotensin II type 2 receptor blockade on mitogen activated protein kinases during myocardial ischemia-reperfusion. Mol Cell Biochem 258:211-218
19. Choi BM, Yoo KH, Bae IS, Oh MH, Hong YS, Lee JW, Kim SK (2005) Angiotensin II-converting enzyme inhibition modulates mitogenic-activated protein kinase family expressions in the neonatal rat kidney. Pediatr Res 57:115-123
20. Spence SG, Zacchei AG, Lee LL, Baldwin CL, Berna RA, Mattson BA, Eydelloth RS (1996) Toxicokinetic analysis of losartan during gestation and lactation in the rat. Teratology 53:245-252
21. Spence SG, Allen HL, Cukierski MA, Manson JM, Robertson RT, Eydelloth RS (1995) Defining the susceptible period of developmental toxicity for AT(1)-selective angiotensin-II receptor antagonist losartan in rats. Teratology 51:367-382
22. Coimbra TM, Janssen U, Grone HJ, Ostendorf T, Kunter U, Schmidt H, Brabant G, Floege J (2000) Early events leading to renal injury in obese Zucker (fatty) rats with type II diabetes. Kidney Int 57:167-182
23. Kliem V, Johnson RJ, Alpers CE, Yoshimura A, Couser WG, Koch KM, Floege J (1996) Mechanism involved in the pathogenesis of tubulointerstitial fibrosis in 5/6 nephrectomized rats. Kidney Int 49:666-678
24. Stambe C, Atkins RC, Hill PA, Nikolic-Paterson DJ (2003) Activation and cellular localization of the p38 and JNK MAPK pathways in rat crescentic glomerulonephritis. Kidney Int 64:2121-2132
25. Hartree EF (1972) Determination of protein: A modification of the Lowry method that gives a linear photometric response. Anal Biochem 48:422-427
26. Haugen HN (1953) The determination of endogenous creatinine in plasma and urine. Scand J Clin Lab Invest 5:48-57
27. Laurell CB (1972) Electroimmunoassay. Scand J Clin Lab Invest 124(Suppl 1):21-37
28. Gavrieli Y, Sherman Y, Ben-Sasson SA (1992) Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 119:493-501
29. Johren O, Dendorfer A, Dominiak P (2004) Cardiovascular and renal function of angiotensin II type 2 receptors. Cardiovasc Res 62:460-467
30. Coles HS, Burne JF, Raff MC (1993) Large-scale normal cell death in the developing rat kidney and its reduction by epidermal growth factor. Development 118:777-784
31. Akil I, Inan S, Gurcu B, Nazikoglu A, Ozbilgin K, Muftuoglu S (2005) Histopathological and ultrastructural effects of Losartan on embrionic rat kidney. Acta Histochem 107:291-300
32. Saward L, Zahradka P (1996) The angiotensin type 2 receptor mediates RNA synthesis in A10 vascular smooth muscle cells. J Mol Cell Cardiol 28:499-506
33. Friberg P, Sundelin B, Bohman SO, Bobik A, Nilsson H, Wickman A, Gustafsson H, Petersen J, Adams MA (1994) Renin-angiotensin system in neonatal rats-induction of renal abnormality in response to ACE-inhibition or angiotensin-II antagonism. Kidney Int 45:485-492
34. Gainer JV, Morrow JD, Loveland A, King DJ, Brown NJ (1998) Effect of bradykinin-receptor blockade on the response to angiotensin-converting-enzyme inhibitor in normotensive and hypertensive subjects. N Engl J Med 339:1285-1292
35. Tan Y, Wang B, Kuem JS, Jaffa AA (2005) Mechanisms of bradykinin induced glomerular injury in diabetes. Am J Physiol Renal Physiol 288:F483-F492
36. Brooks DP, Ruffolo RR Jr (1999) Pharmacological mechanism of angiotensin II receptor antagonists: Implications for the treatment of elevated systolic blood pressure. J Hypertens Suppl 17:S27-32
37. Yang D, Tournier C, Wysk M, Lu HT, Xu J, Davis RJ, Flavell RA (1997) Targeted disruption of the MKK4 gene causes embryonic death, inhibition of c-Jun NH2-terminal kinase activation and defects in AP-1 transcriptional activity. Proc Natl Acad Sci USA 94:3004-3009
38. Francescato HDC, Costa RS, Barbosa Jr F, Coimbra TM (2007) Effect of JNK inhibition on cisplatin-induced renal damage. Nephrol Dial Transplant 22:2138-2148
39. Nath P, Eynott P, Leung S-Y, Adcock IM, Bennett BL, Chung KF (2005) Potential role of c-Jun NH 2 -terminal kinase in allergic airway inflammation and remodeling: Effects of SP600125. Eur J Pharmacol 506:273-283
40. Kumar S, Boehm J, Lee JC (2003) P38 MAP kinases: Key signaling molecules as therapeutic targets for inflammatory diseases. Nat Rev Drug Discov 2:717-726
41. Ferrandi C, Ballerio R, Gaillard P, Giachetti C, Carboni S, Vitte P-A, Gotteland J-P, Cirillo R (2004) Inhibition of c-jun-N-terminal kinase decreases cardiomyocyte apoptosis and infarct size after myocardial ischemia and reperfusion in anaesthetized rats. Br J Pharmacol 142:953-960
42. Naruse K, Fujieda M, Miyazaki E, Hayashi Y, Toi M, Fukui T, Kuroda N, Hiroi M, Kurashige T, Enzan H (2000) An immunohistochemical study of developing glomeruli in human fetal kidneys. Kidney Int 57:1836-1846
43. El Nahas AM, Muchaneta-Kubara EC, Zhang G, Adam A, Goumenos D (1996) Phenotypic modulation of renal cells during experimental and clinical renal scarring. Kidney Int 54:S23-S27
44. Eddy AA (2000) Molecular basis of renal fibrosis. Pediatr Nephrol 15:290-301
45. Chen Y, Lasaitiene D, Gabrielsson BG, Carlsson LM, Billig H, Carlsson B, Marcussen N, Sun XF, Friberg P (2004) Neonatal Losartan treatment suppresses renal expression of molecules involved in cell-cell and cell-matrix interactions. J Am Soc Nephrol 15:1232-1243